| |
TRI group |
TFI group |
| Time from onset to reperfusion (h) |
|
|
| |
6.5±2.4 |
6.4±3.5 |
| Access site crossover |
15(4.41) |
4(1.24)* |
Number of narrowed coronary arteries
0 [n (%)]
1 [n (%)]
2 [n (%)]
3 [n (%)] |
2(0.58)
173(50.88)
98(28.82)
67(19.7) |
1(0.31)
161(50.15)
100(31.15)
59(18.38) |
Pre-PCI TIMI flow
0 [n (%)]
1 [n (%)]
2 [n (%)]
3 [n (%)]
Post-PCI TIMI flow
0 [n (%)]
1 [n (%)]
2 [n (%)]
3 [n (%)] |
284(83.52)
27(7.94)
18(5.29)
11(3.23)
2(0.58)
7(2.05)
23(6.76)
308(90.58) |
277(86.29)
19(5.91)
15(4.67)
10(3.11)
2(0.69)
5(1.55)
20(6.23)
294(91.58) |
IRA
LM[n (%)]
LAD[n (%)]
LCX[n (%)]
RCA[n (%)] |
7(2.05)
178(52.35)
44(12.94)
113(33.23) |
11(3.42)
171(53.27)
37(11.52)
106(33.02) |
| GP IIb/IIIa antagonist [n (%)] |
254(74.7) |
237(73.83) |
| Contrast dose(ml) |
110±29 |
105±38 |
Devices used in PCI
Thrombus aspirator [n (%)]
IABP[n (%)]
Temporary pacemaker[n (%)]
Stent [n (%)]
DES [n (%)] |
259(76.17
12(3.52)
22(6.47)
330(97.05)
309(90.88) |
232(72.17)
17(5.29)
19(5.91)
316(98.44)
299(93.14) |
| Underwent secondary PCI of non-IRA[n (%)] |
56(16.47) |
48(14.95) |
Values are presented as mean ± standard deviation or n (%).